Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001763494-26-000003
Filing Date
2026-02-24
Accepted
2026-02-24 16:05:14
Documents
1
Period of Report
2026-02-20

Document Format Files

Seq Description Document Type Size
1 form4-02242026_040201.html 4  
1 form4-02242026_040201.xml 4 7490
  Complete submission text file 0001763494-26-000003.txt   9108
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Issuer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130
Business Address
Dube Eric M (Reporting) CIK: 0001763494 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36257 | Film No.: 26671525